{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "exchange": "STO", "shortName": "NextCell Pharma AB", "longName": "NextCell Pharma AB", "messageBoardId": "finmb_291736277", "market": "se_market", "marketState": "REGULAR", "earningsTimestamp": 1635505140, "earningsTimestampStart": 1643367540, "earningsTimestampEnd": 1643630400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.04, "sharesOutstanding": 34379500, "bookValue": 3.361, "fiftyDayAverage": 6.1414, "fiftyDayAverageChange": -1.0414, "fiftyDayAverageChangePercent": -0.16957045, "twoHundredDayAverage": 6.7357, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -4.8507504, "regularMarketPrice": 5.1, "regularMarketChange": -0.26000023, "regularMarketTime": 1684143645, "regularMarketDayHigh": 5.32, "regularMarketDayRange": "4.7 - 5.32", "regularMarketDayLow": 4.7, "regularMarketVolume": 20844, "regularMarketPreviousClose": 5.36, "bid": 4.97, "ask": 5.08, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 5.3, "averageDailyVolume3Month": 22398, "averageDailyVolume10Day": 27474, "fiftyTwoWeekLowChange": 0.4000001, "fiftyTwoWeekLowChangePercent": 0.08510641, "fiftyTwoWeekRange": "4.7 - 8.95", "fiftyTwoWeekHighChange": -3.85, "fiftyTwoWeekHighChangePercent": -0.4301676, "fiftyTwoWeekLow": 4.7, "fiftyTwoWeekHigh": 8.95, "twoHundredDayAverageChange": -1.6357002, "twoHundredDayAverageChangePercent": -0.24284041, "marketCap": 181877728, "priceToBook": 1.5174055, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "firstTradeDateMilliseconds": 1499929200000, "priceHint": 2, "symbol": "NXTCL.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Karolinska Institutet Science Park", "address2": "H\u00e4lsov\u00e4gen 7", "city": "Huddinge", "zip": "141 57", "country": "Sweden", "phone": "46 87 35 55 95", "website": "https://www.nextcellpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "NextCell Pharma AB, a biopharmaceutical company, engages in the research, development, and manufacture of novel stem cell therapies in Sweden. The company develops ProTrans, a drug candidate that consists of stem cells for the treatment of autoimmune disease, including type-1 diabetes. It also operates Cellaviva, a stem cell bank. The company was incorporated in 2014 and is based in Huddinge, Sweden.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mathias  Svahn Ph.D.", "age": 46, "title": "Founder & CEO", "yearBorn": 1976, "fiscalYear": 2019, "totalPay": {"raw": 983528, "fmt": "983.53k", "longFmt": "983,528"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anders  Essen-M\u00f6ller M.Sc.", "age": 81, "title": "Chairman", "yearBorn": 1941, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Patrik  Fagerholm", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Lindsay  Davies", "age": 43, "title": "Chief Scientific Officer", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Edvard  Smith", "age": 71, "title": "Medical Director & Director", "yearBorn": 1951, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Sofie Falk Jansson", "age": 36, "title": "Head of Cellaviva", "yearBorn": 1986, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Karin  Gillner", "age": 44, "title": "Head of Quality Assurance", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Sofia  Sisay", "age": 41, "title": "Head of Clinical Trials", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Tacha Zi Plum Forshell", "age": 45, "title": "Head of GMP Facility", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1577750400, "maxAge": 86400}}], "error": null}}